Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases?

Medical Science Monitor

Volumn 7, Issue 1, 2001, Pages 137-141

  Jovanovic, Ivan R ^a   Milosavljevic, Tomica N ^a   Jankovic, Goran P ^a   Micev, Marjan M ^a   Dugalic, Predrag D ^a   Saranovic, Djordjije ^a   Ugljesic, Milenko M ^a   Popovic, Dragan V ^a   Bulajic, Mirko M ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Crohn's disease; Granulormatous gastritis; Helicobacter pylori

Indexed keywords

AMOXICILLIN; MESALAZINE; METRONIDAZOLE; OMEPRAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; COLONOSCOPY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DYSPEPSIA; ENDOSCOPY; ENTERITIS; ERADICATION THERAPY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE;

ABDOMINAL PAIN; ADULT; AMOXICILLIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; DIARRHEA; FEVER; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; MALE; MESALAMINE; METRONIDAZOLE; OMEPRAZOLE;

EID: 0035142426     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Granulomatous gastritis: A morphological and diagnostic approach
2. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease
3. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases A cross-sectional study with matching
4. Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn's disease
5. High frequency of Helicobacter negative gastritis in patients with Crohn's disease
6. Low prevalence of Helicobacter pylori in inflammatory bowel disease: Association with sulphasalazine
7. Helicobacter pylori-positive gastritis in pediatric patients with chronic inflammatory bowel disease
8. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's diseases
9. Long-term follow-up of patients with non-ulcer dyspepsia after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial
10. Clinical features, local and systematic immune response. Gastric mucosal histology, and gastric juice ascorbic acid concentrations
11. Severe gastrointestinal hemorrhage in Crohn's disease
12. Incidence and pattern of peptic ulcer bleeding in a defined geographical area
13. Acute presentation of Campylobacter pylori gastritis
14. Oral, oesophageal and gastroduodenal Crohn's disease
15. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety
16. Focally enhanced gastritis: A frequent type of gastritis in patients with Crohn's disease
17. Gastritis associated with Crohn's disease can be masked by Helicobacter pylori gastritis
18. The concept of type I and type II helper T cells and their cytokines in humans
19. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer
20. Th1 and Th2 cytokine production in low grade B cell gastric MALT-type lymphomas stimulated in vitro with Helicobacter pylori
21. Lymphocytes in the human gastric mucosa during Helicobacter pylori have T helper cell 1 phenotype
22. Helicobacter pylori in kidney allograft recipients: High prevalence of colonization and low incidence of active inflammatory lesions
23. Diseases in pregnancy
24. The rectal mucosa-associated microflora in patients with ulcerative colitis
25. Treatment of ulcerative colitis by implantation of normal colonic flora